New on NCI’s Web sites for March 2025


,
by Daryl McGrath

The precision drugs trial goals to match sufferers to remedies primarily based on the genetics of their most cancers.

Credit score: NHGRI

NCI’s assortment of most cancers data merchandise is consistently rising, so periodically we offer updates on new and up to date content material of curiosity to the most cancers neighborhood.

Information: MyeloMATCH Precision Drugs Trials

NCI has launched myeloMATCH, a precision drugs therapy trial that may take a look at therapy combos focusing on particular genetic modifications in individuals with acute myeloid leukemia and myelodysplastic syndromes.

Current NCI Information Releases

Research led by researchers at NCI and their colleagues at different establishments have been the topic of current NCI information releases, together with:

CCT Inside Most cancers Careers Podcast

NCI’s Middle for Most cancers Coaching (CCT) launched a number of new episodes of its Inside Most cancers Careers podcast. Current episodes embody:

CGH Highlight Weblog

NCI’s Middle for World Well being (CGH) lately printed two new weblog posts: The Essential Function of Analysis in Addressing World Most cancers Stigma, which addresses NCI efforts to help researchers and practitioners in advancing the worldwide discipline of most cancers stigma analysis, and Growing a Low-Price Moveable Know-how to Deal with Cervical Precancer, which discusses a brand new, inexpensive expertise to assist deal with cervical precancers that was developed with NCI funding.

DCP Most cancers Prevention Science Weblog

NCI’s Division of Most cancers Prevention (DCP) added new posts to their Most cancers Prevention Science weblog, together with:

SBIR Innovation Lab Podcast

NCI’s Small Enterprise Innovation Analysis (SBIR) Innovation Lab podcast supplies biotech startups with useful sources. Current podcast episodes embody Launching and Rising a Biotech Startup and Suggestions for Writing a Robust Commercialization Plan. New episodes are printed each different week on main podcast platforms.

Genomic Information Commons Instruments: Exploring the Sequence Reads and BAM Slicing Instruments

A current webinar hosted by NCI’s Middle for Most cancers Genomics provided an overview of the Genomic Information Commons (GDC 2.0) Sequence Reads and BAM Slicing instruments. The Sequence Reads Device lets researchers visualize learn alignments and classify reads supporting both the reference or various alleles primarily based on variant data. The BAM Slicing Device permits customers to obtain particular sections of BAM information, specializing in focused areas with out the necessity for big downloads. 

Nationwide Childhood Most cancers Registry Information Platform

The Childhood Most cancers Information Initiative (CCDI) Platforms and Instruments web page now contains details about the lately launched Nationwide Childhood Most cancers Registry (NCCR) Information Platform. The NCCR Information Platform hyperlinks data for childhood, adolescent, and younger grownup sufferers throughout population-based most cancers registries, permitting knowledge from completely different sources to be matched for a similar individual with out exposing identifiable data. 

Advances in Pancreatic Most cancers Analysis

This up to date web page highlights a few of the newest analysis on pancreatic adenocarcinoma, together with medical advances which will quickly translate into improved care, NCI-supported applications which are fueling progress, and analysis findings from current research.

Advances in Lung Most cancers Analysis

NCI-funded researchers are working to advance our understanding of the best way to stop, detect, and deal with lung most cancers. For instance, scientists have made progress in figuring out many alternative genetic alterations that may drive lung most cancers progress. This web page highlights a few of the newest analysis on non-small cell lung most cancers (NSCLC), the commonest type of lung most cancers.

Most cancers Cachexia

Most cancers cachexia is a losing syndrome that results in weak spot, fatigue, and lack of skeletal muscle (additionally known as sarcopenia) and fats. This new web page describes potential causes of most cancers cachexia, its signs, how suppliers handle cachexia, and the way individuals with cachexia can get assist coping with the bodily issues it may well trigger.

Dealing with Superior Most cancers Lengthy Time period

Lengthy-term most cancers survivors may have most cancers therapy for the remainder of their lives—or go on and off therapy for a few years—to maintain their most cancers at bay. This new web page explains what steps long-term survivors can take to assist their bodily, psychological, and monetary well being throughout this time.

Pores and skin Most cancers in Folks with Darker Pores and skin

Anybody can get pores and skin most cancers, together with individuals with black or brown pores and skin. This new web page talks in regards to the causes of pores and skin most cancers on darker pores and skin, the best way to discover it early, and reveals images of pores and skin most cancers on darker pores and skin tones.

Vitamin Throughout Most cancers Remedy

Most cancers and most cancers therapy may cause modifications in an individual’s vitamin wants. This new web page affords details about good vitamin for individuals with most cancers, frequent modifications that have an effect on vitamin throughout therapy, and the best way to handle modifications so consuming is less complicated.

Weight Modifications, Malnutrition, and Most cancers

This new web page describes weight reduction, weight acquire, and urge for food modifications which are frequent throughout most cancers therapy. It additionally explains how these modifications can result in malnutrition. 

Up to date Reality Sheets

Updates had been made to a number of of NCI’s most cancers data truth sheets, together with:

Up to date Most cancers data Summaries

A number of pages for sufferers on NCI’s web site have been up to date in current months, together with:

Hot Topics

Related Articles